Uhura Bionics, a startup founded by Konrad Zieliński, has launched two wearable devices designed to help people who have lost their voice boxes speak with emotion. The company aims to secure medical device classification in Europe and the U.S. to enable health insurance reimbursement.
The development of advanced wearable voice devices offers a significant improvement in quality of life and communication for individuals who have lost their vocal abilities due to cancer or other conditions, potentially expanding the market for assistive technologies.
Konrad Zieliński, who lost his voice to cancer years ago, has founded Uhura Bionics to create wearable devices that allow individuals who have had their larynxes removed to speak with emotion. Traditional solutions for laryngectomees include handheld speaking devices with robotic voices or surgically implanted prostheses requiring maintenance. Zieliński's non-invasive approach aims to enable users to express a full range of emotions, including laughter and shouting.
Uhura Bionics, selected for TechCrunch Disrupt 2026’s Battlefield 200, offers two products: a basic model and a premium version named Whitney. Zieliński hopes Whitney will become as essential to laryngectomees as glasses are to those with poor eyesight. The company is currently pursuing Class I medical device classification in Europe and the U.S., which would facilitate partial reimbursement through health insurance. Currently, the devices are sold as wellness products, requiring out-of-pocket payment.
Zieliński estimates the market for laryngectomee devices at approximately $2 billion, with potential for growth if Uhura expands to address other speech disorders. The company faces competition from established medical device companies like Atos Medical and other startups. Zieliński plans to demonstrate Whitney's capabilities, including singing, at TechCrunch Disrupt and SF Tech Week.
Pick the topics you care about. Get only what matters, on your cadence.